These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 19079315)
1. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD. Novitzky N; Thomas V; du Toit C; McDonald A Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia. Novitzky N; Thomas V; Stubbings H; Hale G; Waldmann H Cytotherapy; 2004; 6(5):450-6. PubMed ID: 15512911 [TBL] [Abstract][Full Text] [Related]
3. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944 [TBL] [Abstract][Full Text] [Related]
5. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience. Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614 [TBL] [Abstract][Full Text] [Related]
6. Conditioning with purine analogs leads to good engraftment rates of immunodepleted grafts for aplastic anemia. Novitzky N; Thomas V; du Toit C Biol Blood Marrow Transplant; 2013 Apr; 19(4):584-8. PubMed ID: 23270985 [TBL] [Abstract][Full Text] [Related]
7. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221 [TBL] [Abstract][Full Text] [Related]
8. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. Al-Zahrani H; Nassar A; Al-Mohareb F; Al-Sharif F; Mohamed S; Al-Anazi K; Patel M; Rasheed W; Saleh AJ; Bakr M; Ahmed S; Ibrahim K; Hussain F; Elkum N; Elhassan T; Nurgat Z; Chaudhri N; Aljurf M Biol Blood Marrow Transplant; 2011 May; 17(5):717-22. PubMed ID: 20736079 [TBL] [Abstract][Full Text] [Related]
10. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172 [TBL] [Abstract][Full Text] [Related]
11. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. de la Fuente J; Reiss S; McCloy M; Vulliamy T; Roberts IA; Rahemtulla A; Dokal I Bone Marrow Transplant; 2003 Oct; 32(7):653-6. PubMed ID: 13130311 [TBL] [Abstract][Full Text] [Related]
12. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. Seidel MG; Fritsch G; Matthes-Martin S; Lawitschka A; Lion T; Pötschger U; Rosenmayr A; Fischer G; Gadner H; Peters C Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578 [TBL] [Abstract][Full Text] [Related]
14. Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation. Blau IW; Schmidt-Hieber M; Leschinger N; Göldner H; Knauf W; Hopfenmüller W; Thiel E; Blau O Ann Hematol; 2007 Aug; 86(8):583-9. PubMed ID: 17468869 [TBL] [Abstract][Full Text] [Related]
15. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation]. Wu B; Guo K; Song Z; Yan D; Yang Y; Xiao L Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):194-7. PubMed ID: 12133456 [TBL] [Abstract][Full Text] [Related]
16. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427 [TBL] [Abstract][Full Text] [Related]
17. Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation. Wäsch R; Reisser S; Hahn J; Bertz H; Engelhardt M; Kunzmann R; Veelken H; Holler E; Finke J Bone Marrow Transplant; 2000 Aug; 26(3):243-50. PubMed ID: 10967561 [TBL] [Abstract][Full Text] [Related]
19. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990 [TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning. Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]